320 related articles for article (PubMed ID: 19046357)
1. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
Calcagno E; Carli M; Baviera M; Invernizzi RW
J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
Ceglia I; Carli M; Baviera M; Renoldi G; Calcagno E; Invernizzi RW
J Neurochem; 2004 Oct; 91(1):189-99. PubMed ID: 15379899
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors.
Calcagno E; Carli M; Invernizzi RW
J Neurochem; 2006 Feb; 96(3):853-60. PubMed ID: 16405507
[TBL] [Abstract][Full Text] [Related]
4. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
Mirjana C; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
[TBL] [Abstract][Full Text] [Related]
5. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
Agnoli L; Carli M
Psychopharmacology (Berl); 2012 Jan; 219(2):633-45. PubMed ID: 22113450
[TBL] [Abstract][Full Text] [Related]
6. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
[TBL] [Abstract][Full Text] [Related]
7. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
Carli M; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
Fletcher PJ; Tampakeras M; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2007 Dec; 195(2):223-34. PubMed ID: 17673981
[TBL] [Abstract][Full Text] [Related]
9. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
Fletcher PJ; Rizos Z; Noble K; Higgins GA
Neuropharmacology; 2011 Sep; 61(3):468-77. PubMed ID: 21402085
[TBL] [Abstract][Full Text] [Related]
10. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
13. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
[TBL] [Abstract][Full Text] [Related]
14. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
15. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
16. Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP.
Carli M; Calcagno E; Mainini E; Arnt J; Invernizzi RW
Psychopharmacology (Berl); 2011 Apr; 214(3):625-37. PubMed ID: 21049266
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
18. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
Fletcher PJ; Rizos Z; Noble K; Soko AD; Silenieks LB; Lê AD; Higgins GA
Neuropharmacology; 2012 Jun; 62(7):2288-98. PubMed ID: 22342986
[TBL] [Abstract][Full Text] [Related]
19. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
Ardayfio PA; Benvenga MJ; Chaney SF; Love PL; Catlow J; Swanson SP; Marek GJ
J Pharmacol Exp Ther; 2008 Dec; 327(3):891-7. PubMed ID: 18772320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
